Drug Shortage Report for ACT AMLODIPINE

Last updated on 2021-01-07 History
Report ID 127998
Drug Identification Number 02297485
Brand name ACT AMLODIPINE
Common or Proper name AMLODIPINE 5MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) AMLODIPINE
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 500
ATC code C08CA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-11-04
Estimated end date 2020-12-31
Actual end date 2021-01-06
Shortage status Resolved
Updated date 2021-01-07
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-01-07 French Compare
v3 2021-01-07 English Compare
v2 2020-11-06 French Compare
v1 2020-11-06 English Compare